SCHEMBL387029

SCHEMBL387029

FC1C[CH]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL575107 0.84
SCHEMBL6442980 0.84
SCHEMBL477683 0.84
SCHEMBL477826 0.82
SCHEMBL478035 0.81
SCHEMBL26166 0.81
SCHEMBL2533604 0.80
SCHEMBL14608703 0.73
SCHEMBL183710 0.73
SCHEMBL477991 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 782 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116910-A1 Heterocycles as WIP1 Inhibitors PMV PHARMACEUTICALS, INC. 2024-04-11 US claimed
US-11713299-B2 Histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-08-01 US claimed
CN-111201226-B Cyclic substituted imidazo [4,5-c ] quinoline derivatives 辉瑞大药厂 2022-07-22 CN claimed
EP-3592740-B1 CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES PFIZER (US) 2022-02-09 EP claimed
US-11161844-B2 Cyclic substituted imidazo[4,5-c]quinoline derivatives PFIZER INC. (US) 2021-11-02 US claimed
US-20210107876-A1 HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2021-04-15 US claimed
CN-111201226-A Cyclic substituted imidazo [4,5-c ] quinoline derivatives 辉瑞大药厂 2020-05-26 CN claimed
US-20200039977-A1 CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES PFIZER (US) 2020-02-06 US claimed
EP-3558971-A1 HISTONE METHYLTRANSFERASE INHIBITORS Global Blood Therapeutics, Inc. (US) 2019-10-30 EP claimed
WO-2018163030-A1 CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES PFIZER INC. (US) 2018-09-13 WO claimed
WO-2018119208-A1 HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2018-06-28 WO claimed
US-7829586-B2 Aryl-substituted nitrogen-containing heterocyclic compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-11-09 US claimed
US-20090275617-A1 Aryl-Substituted Nitrogen-Containing Heterocyclic Compounds MSD K.K. (JP) 2009-11-05 US claimed
EP-1935881-A1 ARYL-SUBSTITUTED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-06-25 EP claimed
US-5948792-A POTENT AND SELECTIVE ANTAGONISTS FOR MUSCARINIC M.SUB.3 RECEPTORS WITH LITTLE SIDE EFFECTS. BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-09-07 US claimed
EP-0930298-A1 FLUORINATED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1999-07-21 EP claimed
CN-118355017-A Bicyclic compounds for controlling invertebrate pests 巴斯夫欧洲公司 2024-07-16 CN disclosed
EP-4396173-A1 HERBICIDAL MALONAMIDES CONTAINING A CONDENSED RING SYSTEM BASF SE (DE) 2024-07-10 EP disclosed
EP-0150677-B1 HERBICIDAL AND INSECTICIDAL TRIAZINONES CIBA-GEIGY AG (CH) 1989-01-18 EP disclosed
EP-0150677-A1 Herbicidal and insecticidal triazinones CIBA-GEIGY AG (CH) 1985-08-07 EP disclosed